腎素抑制藥 的英文怎麼說

中文拼音 [shènsùyìzhìyào]
腎素抑制藥 英文
inhibitor renin
  • 腎 : 名詞[生理學] （腎臟） kidney
  • 素 : Ⅰ形容詞1 （本色; 白色） white 2 （顏色單純） plain; simple; quiet 3 （本來的; 原有的） native Ⅱ名...
  • 抑 : Ⅰ動詞（向下按; 壓制） restrain; repress; curb Ⅱ連詞[書面語]1 （表示抉擇） or 2 （表示轉折） but3 ...
  • 制 : Ⅰ動詞1 （製造） make; manufacture 2 （擬訂; 規定） draw up; establish 3 （用強力約束; 限定; 管束...
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 抑制 : 1 （控制） restrain; control; check; hold up; curb; stop; repress; bridle; choke; prehension; sup...
  1. Duloxetine is a new antidepressant and a dual inhibitor of serotonin and norepinephrine reuptake

    摘要度洛西汀是一種新型的抗抑鬱藥，為5 -羥色胺和去甲腎上腺素再攝取的雙重抑制劑。
  2. Among antihypertensive measures, blockade of the raas by means of ace inhibitors or angiotensin ii receptor antagonists recently emerged as a potentially polyvalent approach, not only for treating hypertension and reducing cardiovascular events, but also to prevent or reduce albuminuria, counteract diabetic nephropathy and lower the occurrence of new type 2 diabetes in individuals at risk

    在抗高血壓藥物治療中，通過用ace抑制劑或血管緊張素受體拮抗劑可阻滯腎素-血管緊張素-醛固酮系統激活，最近其可作為一種潛在多能的治療方法，不僅可治療高血壓和減少心血管事件，也能夠預防或減少蛋白尿，阻止糖尿病性腎病變，並使新糖尿病患者發生風險性降得更低。
  3. Renin inhibitor. and we have more new drugs is under investigating

    腎素抑制劑。也有很多新藥在進行研究。
  4. Mancia : well ， no question that rennin inhibitors are a new class of agents ， promising agents

    嗯，腎素抑制劑確實是一種新藥，一種很有前景的藥物。
  5. [ b ] mancia : [ / b ] well ， no question that rennin inhibitors are a new class of agents ， promising agents

    嗯，腎素抑制劑確實是一種新藥，一種很有前景的藥物。
  6. If these would demonstrate that then there would be an even stronger rationale to use rennin inhibitors alone or in combination

    如果這一點得到證實的話，那麼我們就會更有理由在單獨用藥和聯合治療中使用腎素抑制劑了。
  7. Results the inhibitory effects of three vasodilators on norepinephrine concentration - response curves were more powerful than that on potassium chloride concentration - response curves

    結果色滿卡林、福斯考林、硝酸甘油對去甲腎上腺素量效曲線的抑制強度明顯高於三藥對氯化鉀量效曲線的抑制。
  8. European medicines agency expert committee concluded that prozac - type serotonin - selective reuptake inhibitors ( ssri ) and serotonin - norepinephrine reuptake inhibitors ( snri ) were associated with increased suicide - related behaviour and hostility in young people

    一個歐洲醫療署的專家委員會得出結論指出，百憂解類的選擇性血清再吸收抑制劑（ ssri ）及血清促進素及正腎上腺素再吸收抑制劑（ snri ）抗憂郁藥，與年輕人自殺相關行為及敵意舉止增加有關。
  9. In the study, three drugs were gien to the olunteers : ssri ( serotonin specific reuptake inhibitor ) to raise serotonin leels ; nari ( noradrenaline reuptake inhibitor ) to raise noradrenaline leels ( another neurotransmitter important in depression, and also found in taste buds ) ; and an inactie placebo

    在該項研究中，志願者服用的三種藥物是：提高5 -羥色胺水平的ssri （選擇性5 -羥色胺再攝取抑制劑） ，提高去甲腎上腺素（另外一種對抑鬱癥有重要作用的神經遞質，也存在於味蕾中）水平的nari （去甲腎上腺素再攝取抑制劑） ，以及無活性的安慰劑。
  10. Our aim was to determine whether inhibitors of the renin - angiotensin - aldosterone system, which can reduce entricular hypertrophy and myocardial fibrosis, can improe diastolic function to a greater extent than can other antihypertensie agents

    腎素-血管緊張素-醛固酮系統可以減小心室肥大和減少心肌纖維化，我們的目的就是確定這一系統的抑制劑是否比其它抗高血壓藥物能更好地改善心臟舒張功能。
  11. It has been found that the hypofunction status of hypothalamuspituitaryadrenal axis exists in patients with shenyang deficiency syndrome of tcm, also presents in most asthma patients. seasonal attack of asthma can be prevented with shentonifying drugs by improving adrenocortical function

    Hpa軸功能減退也見于大部分哮喘患者，補腎藥通過提高腎上腺皮質功能從而預防哮喘季節性發作長期應用激素患者，其hpa軸受抑制而功能低下，據此採用補腎藥可提高激素撤除成功率。
  12. Seasonal attack of asthma can be prevented with shentonifying drugs by improving adrenocortical function. since patients subject to longterm glucocorticoids display hypofunction condition of hpa axis, shentonifying drugs should be helpful to gluocorticoid withdrawal for getting higher success rate

    Hpa軸功能減退也見于大部分哮喘患者，補腎藥通過提高腎上腺皮質功能從而預防哮喘季節性發作長期應用激素患者，其hpa軸受抑制而功能低下，據此採用補腎藥可提高激素撤除成功率。
  13. It has been found that the hypofunction status of hypothalamuspituitaryadrenal axis exists in patients with shenyang deficiency syndrome of tcm, also presents in most asthma patients. seasonal attack of asthma can be prevented with shentonif.

    Hpa軸功能減退也見于大部分哮喘患者，補腎藥通過提高腎上腺皮質功能從而預防哮喘季節性發作長期應用激素患者，其hpa軸受抑制而功能低下，據此採用補腎藥可提高激素撤除成功率。
分享友人
分享到 Line

分享到臉書